Shuai Bai

Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer

Yan Guo, Yuan Yao, Ying Fu, 2020, Cancer Immunology, Immunotherapy.

Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system

J. Pacheco, Jiandong Zhang, M. Tachihara, 2021, Translational lung cancer research.

A CT-based radiomics signature for evaluating tumor infiltrating Treg cells and outcome prediction of gastric cancer

Z. Ye, Y. Liu, Yuwei Zhang, 2020, Annals of translational medicine.

Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma

X. Ren, F. Wei, Congfang Guo, 2019, Front. Oncol..

The effects of TNF‐α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer

Hui Li, Yang Qu, Gang Zhao, 2021, International journal of cancer.